Now Enrolling: Alzheimer’s Study

Alzheimer’s disease affects over 5 million Americans and is the most common cause of dementia among older adults. Currently available treatments for Alzheimer’s are limited, and while they can improve symptoms they do not alter the progression of the disease. So scientists are working to develop new treatments to stop this disease.

Clinvest Research wants to help.

The doctors and staff at the Missouri Memory Center are conducting a research study for people ages 55 to 85 years of age who suffer from mild to moderate Alzheimer’s disease. Participants who complete the main study will be offered the opportunity take part in an open-label extension of this study in which both you and the study doctor will know which study drug is given.

Study Participants receive:

  • Study related medical evaluations and study related monitoring at no cost
  • Investigational medication or inactive substance at no cost
  • Compensation for participant and caregiver for time and travel

 

Sign up to learn more!